11 research outputs found
Metastatic Biomarkers in Synovial Sarcoma
Synovial sarcoma (SS) is an aggressive soft tissue sarcoma (STS) that typically occurs in the extremities near a joint. Metastatic disease is common and usually occurs in the lungs and lymph nodes. Surgical management is the mainstay of treatment with chemotherapy and radiation typically used as adjuvant treatment. Although chemotherapy has a positive impact on survival, the prognosis is poor if metastatic disease occurs. The biology of sarcoma invasion and metastasis remain poorly understood. Chromosomal translocation with fusion of the SYT and SSX genes has been described and is currently used as a diagnostic marker, although the full impact of the fusion is unknown. Multiple biomarkers have been found to be associated with SS and are currently under investigation regarding their pathways and mechanisms of action. Further research is needed in order to develop better diagnostic screening tools and understanding of tumor behavior. Development of targeted therapies that reduce metastatic events in SS, would dramatically improve patient prognosis
A Cell Cycle Role for the Epigenetic Factor CTCF-L/BORIS
CTCF is a ubiquitous epigenetic regulator that has been proposed as a master keeper of chromatin organisation. CTCF-like,
or BORIS, is thought to antagonise CTCF and has been found in normal testis, ovary and a large variety of tumour cells. The
cellular function of BORIS remains intriguing although it might be involved in developmental reprogramming of gene
expression patterns. We here unravel the expression of CTCF and BORIS proteins throughout human epidermis. While CTCF
is widely distributed within the nucleus, BORIS is confined to the nucleolus and other euchromatin domains. Nascent RNA
experiments in primary keratinocytes revealed that endogenous BORIS is present in active transcription sites. Interestingly,
BORIS also localises to interphase centrosomes suggesting a role in the cell cycle. Blocking the cell cycle at S phase or
mitosis, or causing DNA damage, produced a striking accumulation of BORIS. Consistently, ectopic expression of wild type
or GFP- BORIS provoked a higher rate of S phase cells as well as genomic instability by mitosis failure. Furthermore, downregulation
of endogenous BORIS by specific shRNAs inhibited both RNA transcription and cell cycle progression. The results
altogether suggest a role for BORIS in coordinating S phase events with mitosis